Limits...
Usefulness of marking alkaline phosphatase and C-reactive protein in monitoring the risk of preterm delivery.

Huras H, Ossowski P, Jach R, Reron A - Med. Sci. Monit. (2011)

Bottom Line: In more than half of women (72.1%) from study group, CRP level exceeded 7 mg/l; in the control group, the CRP level exceeded 7 mg/l in 35% of cases.Significantly higher levels of CRP (above 20 mg/l) and ALP (above 300 u/l) were found in the 18 patients from the study group compared to the control group.Although an increase in the level of ALP in serum cannot be an absolute and sole marker of the risk of preterm delivery, it can be used in conjunction with a significantly elevated CRP level.

View Article: PubMed Central - PubMed

Affiliation: Department of Obstetrics and Perinatology Jagiellonian University, Cracow, Poland. huberthuras@wp.pl

ABSTRACT

Background: The purpose of this paper is to compare the effectiveness of use of alkaline phosphatase (ALP) and C-reactive protein (CRP) levels in marking and monitoring the risk of preterm delivery due to infection.

Material/methods: The study involved 83 patients assigned to groups: Group I (n=43) consisted of patients hospitalized for symptoms of preterm delivery, and Group II (control group n=40) consisted of patients controlled or hospitalized delivering on time without complications, whose pregnancy had a physiological course. All patients had a single marking of ALP and CRP levels in serum performed.

Results: CRP levels were within the range 7 mg/l to 94 mg/l in the study group, and 4.83 mg/l to 90 mg/l in the control group. The level of ALP in the study group ranged from 139 u/l to 368 u/l and from 218 u/l to 321 u/l in the control group. In more than half of women (72.1%) from study group, CRP level exceeded 7 mg/l; in the control group, the CRP level exceeded 7 mg/l in 35% of cases. Significantly higher levels of CRP (above 20 mg/l) and ALP (above 300 u/l) were found in the 18 patients from the study group compared to the control group.

Conclusions: Although an increase in the level of ALP in serum cannot be an absolute and sole marker of the risk of preterm delivery, it can be used in conjunction with a significantly elevated CRP level.

Show MeSH

Related in: MedlinePlus

Distribution of patients depending on period of gestation.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3539487&req=5

f2-medscimonit-17-11-cr657: Distribution of patients depending on period of gestation.

Mentions: The largest group of pregnant women (67.4%) with symptoms indicating the threat of preterm delivery was formed by women hospitalized between weeks 33 and 36 of the gestation period (Table 2 and Figure 2).


Usefulness of marking alkaline phosphatase and C-reactive protein in monitoring the risk of preterm delivery.

Huras H, Ossowski P, Jach R, Reron A - Med. Sci. Monit. (2011)

Distribution of patients depending on period of gestation.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3539487&req=5

f2-medscimonit-17-11-cr657: Distribution of patients depending on period of gestation.
Mentions: The largest group of pregnant women (67.4%) with symptoms indicating the threat of preterm delivery was formed by women hospitalized between weeks 33 and 36 of the gestation period (Table 2 and Figure 2).

Bottom Line: In more than half of women (72.1%) from study group, CRP level exceeded 7 mg/l; in the control group, the CRP level exceeded 7 mg/l in 35% of cases.Significantly higher levels of CRP (above 20 mg/l) and ALP (above 300 u/l) were found in the 18 patients from the study group compared to the control group.Although an increase in the level of ALP in serum cannot be an absolute and sole marker of the risk of preterm delivery, it can be used in conjunction with a significantly elevated CRP level.

View Article: PubMed Central - PubMed

Affiliation: Department of Obstetrics and Perinatology Jagiellonian University, Cracow, Poland. huberthuras@wp.pl

ABSTRACT

Background: The purpose of this paper is to compare the effectiveness of use of alkaline phosphatase (ALP) and C-reactive protein (CRP) levels in marking and monitoring the risk of preterm delivery due to infection.

Material/methods: The study involved 83 patients assigned to groups: Group I (n=43) consisted of patients hospitalized for symptoms of preterm delivery, and Group II (control group n=40) consisted of patients controlled or hospitalized delivering on time without complications, whose pregnancy had a physiological course. All patients had a single marking of ALP and CRP levels in serum performed.

Results: CRP levels were within the range 7 mg/l to 94 mg/l in the study group, and 4.83 mg/l to 90 mg/l in the control group. The level of ALP in the study group ranged from 139 u/l to 368 u/l and from 218 u/l to 321 u/l in the control group. In more than half of women (72.1%) from study group, CRP level exceeded 7 mg/l; in the control group, the CRP level exceeded 7 mg/l in 35% of cases. Significantly higher levels of CRP (above 20 mg/l) and ALP (above 300 u/l) were found in the 18 patients from the study group compared to the control group.

Conclusions: Although an increase in the level of ALP in serum cannot be an absolute and sole marker of the risk of preterm delivery, it can be used in conjunction with a significantly elevated CRP level.

Show MeSH
Related in: MedlinePlus